Contributions of major smoking-related diseases to reduction in life expectancy associated with smoking in Chinese adults: a cross-sectional study by unknown
Han et al. BMC Public Health 2013, 13:1147
http://www.biomedcentral.com/1471-2458/13/1147RESEARCH ARTICLE Open AccessContributions of major smoking-related diseases
to reduction in life expectancy associated with
smoking in Chinese adults: a cross-sectional study
Wei Han1†, Jingmei Jiang1†, Junyao Li2, Xianjia Zeng1, Xiaonong Zou2, Yanping Wu2, Yuanli Chen2, Ping Zhao2,
Lei Hou1, Haiyu Pang1 and Boqi Liu2*Abstract
Background: Cigarette smoking is a prominent risk factor for a wide range of diseases. The current study aimed to
evaluate the impact of smoking on deaths from major smoking-related diseases (neoplasms, vascular diseases and
respiratory diseases) in Chinese adults by estimating the potential gains in life expectancy (LE) that would accrue
from eliminating deaths from these diseases, and to determine the contribution of each disease to the reduction in
LE associated with smoking.
Methods: Two cohorts of Chinese smokers and non-smokers were constructed from a retrospective national
mortality survey that had been conducted in 1989–1991 and included one million all-cause deaths among adults
during 1986–1988 in 103 geographical regions. For each cohort, potential gains in LE by eliminating deaths from
each major smoking-related disease were estimated. The contributions of each disease to smoking-associated
reduction in LE were assessed using the LE decomposition approach.
Results: Among the major smoking-related diseases, it was estimated that elimination of vascular diseases would
provide the greatest potential gain in LE (years), regardless of smoking status. The gains for smokers versus
non-smokers in populations of urban men, urban women, rural men and rural women aged 35 years were 3.5 vs. 4.3,
3.8 vs. 4.1, 2.4 vs. 3.0, and 2.6 vs. 2.9 years, respectively. Respiratory diseases contributed most to smoking-associated LE
reductions in urban women, rural men and rural women of 43.6%, 46.4%, and 62.9%, respectively. In urban men,
neoplasms contributed most to smoking-associated LE reduction, their contribution being estimated as 45.8%.
Conclusions: Respiratory disease has the greatest influence on the LE reduction associated with smoking. Thus,
smoking prevention could significantly reduce deaths from respiratory disease and improve LE.
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Worldwide, many studies have shown that cigarette smok-
ing increases the risk of death and is a prominent risk factor
for a wide range of diseases such as neoplasms, respiratory
diseases and vascular diseases [1-3]. Although these find-
ings are meaningful from an etiological perspective, they fail
to provide information regarding absolute public health ef-
fects. Life expectancy (LE) by smoking status, an effective* Correspondence: boqiliu@163.com
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reproduction in any medium, provided the ormeasure of the health burden associated with smoking, has
the advantage of being easy for both the general public and
policymakers to interpret and understand.
The greatest challenge to estimating the impact of
smoking-related diseases by determining LE in a large-scale
representative cross-sectional study is the construction
of cohorts of smokers and non-smokers, because of the
difficulty in obtaining accurate information about smoking
habits. Until now, only a few reports have directly estimated
the reduction in LE caused by smoking [4-10]; most of
these were based on cohort studies. Construction of cohort
studies by smoking status to estimate mortality or disease
incidence is time-consuming. Moreover, although such. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ing status, they have not identified which diseases make
the greatest contributions to these differences. More data
on the impact of different diseases and smoking status on
mortality would provide useful data that could help public
health providers to target efforts to attenuate the reduction
in LE caused by smoking.
China, the world’s largest cigarette producer and con-
sumer, has a particularly large health burden associated
with smoking [11,12]. Therefore, there is an urgent need
to provide an accurate assessment of the health burden
caused by smoking and thus facilitate shaping of the
most effective public health policies for smoking pre-
vention and cessation.
During 1989–1991, a large nationwide retrospective study
of smoking and mortality was conducted in a population
of 27 million adults (35 years old or above) in 103 regions
(24 major cities and 79 counties) of China [13]. The 24
cities were chosen non-randomly to cover a wide geo-
graphical region. Stratified random sampling techniques
were used to choose 79 counties from 2000 counties whose
cancer rates were recorded in the Chinese cancer atlas
(yielding a population of 67 million). After this survey,
a series of studies were conducted and their findings
published, most estimating the impact of smoking on risk
of death from a particular disease from an etiological
perspective [13-15].
The present study aimed to further investigate the in-
fluences of various major smoking-related diseases on the
reduction in LE, as well as the contribution of each disease
to the smoking-related reduction in LE.
Methods
The total population (approximately 27 million aged 35 years
or older) from which the nationwide mortality survey was
conducted during 1989–1991 was defined as the base popu-
lation. Approximately 90% of subjects (almost one million)
who had died in 1986–1988 were identified from the
base population, as were their surviving spouses. Thus, the
present study involved three populations: the base popula-
tion, deceased subjects and their surviving spouses.
Causes of death were identified by reviewing the death
certificates from the local Population Administrative
Offices. If necessary, this information was supplemented
by reviewing the medical records or by discussion (a few
years after the death) with local health workers, family
members or both. Underlying causes of death from the
Population Administrative Offices records were coded
according to the International Classification of Diseases,
9th Revision (ICD-9). Details of the study design, field
survey methods and participants have been described
elsewhere [13]. In the present study, major smoking-related
causes of deaths included: neoplasms (ICD-9: 140–208),
respiratory diseases (chronic obstructive pulmonary disease:490–2, 496, 416–7; respiratory tuberculosis: 011, 012, 018;
other respiratory diseases: rest of 460–519), and vascular
diseases (stroke: 430–9; ischemic heart disease: 410–4;
other vascular diseases: 390–409, 415, 418–429, 440–459);
the remaining deaths were categorized as related to other
causes.
The smoking habits of the deceased subjects were
ascertained by interviewing their living spouses or other
relatives to determine whether the subjects had smoked
before 1980, a period of time before the onset of the
disease that would have eventually caused death during
1986–1988. In addition, the smoking habits of the
spouses of the deceased subjects were also determined
during these interviews. Almost 100% of all identified
households agreed to participate in the interview. In this
investigation, non-smokers were defined as persons who
had never smoked during their lifetime or who had only
smoked infrequently at a young age.
To ascertain the smoking prevalence of the base
population, a new design was employed in the present
study, which used the prevalence of smoking of living
spouses as a substitute for the smoking prevalence of
the base population. The assumption of this design is
that living spouses constituted an approximately random
sample of the base population with similar smoking habits
to those of the study base.
Life tables and cause-deleted life table construction
Numbers of smokers and non-smokers in the base popula-
tion stratified by age group were estimated by applying age-
specific factors based on the proportions of smokers among
spouses. During this process, 6% of the sample for whom no
smoking information was available were excluded and the
base population estimate was reduced by 10% because infor-
mation on only 90% of deaths was available. The number of
deaths per annum was calculated by dividing the total num-
ber of deceased subjects by three (number of study years).
After these adjustments, the abridged life table technique
was used to construct cause-deleted life tables for smokers
and non-smokers separately by sex and area of residence
(urban or rural), to assess the potential gains in LE by elim-
inating deaths from major smoking-related diseases [16].
Cause-specific decomposition of LE reduction associated
with smoking
As proposed by Preston et al. [17], the following equation
(1) can be used to determine the difference in LE between
smokers and non-smokers that is attributable to mutually
independent death causes.
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into two terms the difference in gained LE between
smokers and non-smokers when deaths from a major
smoking-associated disease have been eliminated.

















where, e(35) and e*(35) represent the LE for 35-year-old
non-smokers and smokers, respectively; Di(35) and Di 35ð Þ
represent the gain in LE at age 35 years for non-smokers
and smokers, respectively, by eliminating cause of death i;
and where nLx,i, nLx;i , nLx,− i, and nL

x;−i represent the
person-years alive between ages x and x + 5 for non-
smokers and smokers in life tables for causes i and –i,
respectively.
The first term represents the change in survival from
cause –i weighted by the cumulative probability of sur-
viving from cause i; the second term represents the
change in survival from cause i weighted by the cumulative
probability of surviving from cause –i: the LE disparity
between smokers and non-smokers is thus attributable
to cause i [17]. Therefore, a change in significance of a
certain cause of death results from the combined ef-
fects of a change in cause i and changes in causes other
than i.
Results
Of the base population, there were 1 059 804 deceased
subjects (69.5% urban, 30.5% rural) and 307 853 living
spouses (76.1% urban, 23.9% rural) aged 35 years or over in
this study. The smoking prevalence among living spouses
of the deceased subjects was 57.3% for men and 17.7%
women in urban areas, and 64.1% and 8.6%, respectively,
in rural areas. Table 1 presents the all-cause mortality
rates by smoking status in the base population. The mor-
tality rates among smokers were higher than among non-
smokers for the age groups older than 50 years, regardless
of sex and area of residence.
Number of deaths from major smoking-associated diseases
Figure 1 presents the sex- and area-specific number of
deaths from major smoking-related diseases for each
age interval. Neoplasms, vascular diseases and respira-
tory diseases together account for the majority of deaths
in Chinese adults. Almost 81.1% and 78.9% of the total
deaths were attributable to one of these three diseases
in urban men and women, respectively; in the rural
population the corresponding proportions were lower at
75.3% and 75.1%, respectively.Deaths from these smoking-related diseases were con-
centrated in different age groups. Deaths from neoplasms
mostly occurred between 35 and 69 years and accounted
for approximately two-thirds of all neoplasm-related
deaths, regardless of sex and location. Compared with neo-
plasms, a larger proportion of deaths from vascular diseases
or respiratory diseases occurred in later life, approximately
two-thirds of deaths from respiratory or vascular diseases
occurring at 70 years or older.
Differences in LE according to smoking status and
potential gains in LE related to elimination of major
smoking-associated diseases
Tables 2 and 3 presents the estimated LE of smokers and
non-smokers of different ages, as well as the potential gains
in LE by the hypothesized elimination of deaths from each
of the three diseases in subjects over 35 years old. In gen-
eral, non-smokers had longer LEs than smokers, regardless
of sex or area of residence. The all-cause LE (years) differ-
ence between 35-year-old smokers and non-smokers was
2.6 and 2.4, for urban men and women, respectively, and
2.3 and 2.9 for rural men and women, respectively.
Overall, after the hypothesized elimination of deaths
from respiratory diseases or neoplasms for smokers
and non-smokers aged 35 years and above, the poten-
tial gains in LE (years) for smokers was greater than
for non-smokers at every age, regardless of sex or area
of residence. However, it did not follow the same pat-
tern for vascular disease: non-smokers would poten-
tially gain more in LE than smokers after elimination
of deaths from vascular diseases.
Contributions of major smoking-related diseases to the
LE reduction associated with smoking
Column 3 of Table 4 presents the differences between
smokers and non-smokers in the potential gains in LE
according to each of three major smoking-related diseases
and columns 4 and 5 show the results of decomposition
of these differences, which correspond to the first term
and second terms in equation (2). The values in column 3
are all positive except for that for vascular diseases: this
indicates that the potential gains in LE related to vascular
diseases are greater for non-smokers than for smokers.
However, for all major smoking-related diseases the sec-
ond terms in equation (2) are positive, indicating that the
LE of smokers would have increased more than that of
non-smokers if deaths from one of these three causes had
been removed after taking changes in mortality from other
diseases into account.
Figure 2 shows the reduction in LE associated with smok-
ing that was attributable to a particular smoking-associated
cause of death (second term in equation [2]): the relative
importance of a particular smoking-associated disease
varied according to sex and area of residence. For urban
Table 1 Sex- and area-specific numbers of subjects in the base population and annual all-cause mortality rates by
smoking status during 1986–1988

















n % n % n % n %
35-39 1175320 0.1 431648 0.2 49392 0.1 20002 0.2
40-44 803444 0.2 355561 0.4 64568 0.2 19444 0.4
45-49 645155 0.4 298267 0.6 107316 0.4 30337 0.5
50-54 640748 0.9 277814 1.0 168475 0.7 34168 0.9
55-59 624586 1.4 245723 1.7 180234 1.1 31875 1.3
60-64 484225 2.4 193866 3.0 146389 1.9 29220 2.2
65-69 332614 4.2 138917 4.7 110927 3.3 22650 3.8
70-74 195844 7.6 89244 7.8 75321 5.9 17501 6.2
75-79 102896 11.5 48351 11.1 46026 9.0 10754 9.0
80+ 51585 20.3 24237 21.0 32615 17.2 7876 17.3
Non-smoker
35-39 681426 0.2 231406 0.3 1636345 0.1 589816 0.2
40-44 554413 0.2 187198 0.4 1226796 0.2 472812 0.3
45-49 455417 0.4 153790 0.6 920613 0.3 388111 0.4
50-54 454735 0.7 135293 0.9 898500 0.6 342135 0.7
55-59 396313 1.1 110449 1.5 764389 0.9 308307 1.0
60-64 329189 1.6 97838 2.3 583003 1.4 261815 1.6
65-69 229804 2.9 77465 3.3 418809 2.4 208706 2.5
70-74 155509 5.2 57105 5.2 301473 4.1 151593 4.4
75-79 94981 8.3 37820 6.8 192822 6.9 103161 6.1
80+ 69195 15.0 24637 14.0 174729 14.4 77735 13.7
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associated LE reduction, followed by respiratory diseases
and vascular diseases (neoplasms: 45.8%, respiratory dis-
eases: 35.0%, vascular diseases: 14.8%). For urban women,
and rural men and women, the relative importance of the
contributions of major smoking-related diseases followed
a different pattern; the contributions of respiratory diseases,
neoplasms and vascular diseases being 43.6%, 37.2%
and 19.2%, respectively, in urban women; 46.4%, 37.4% and
13.6%, respectively, in rural men; and 62.9%, 22.0% and
14.5%, respectively, in rural women.
Discussion and conclusion
Overall, we found that non-smokers lived more than 2 years
longer than smokers. Respiratory disease, neoplasms and
vascular disease all had a considerable influence in reducing
LE associated with smoking, but to varying degrees. Nearly
78.6% of all deaths were attributable to one of the three
major smoking-related diseases in Chinese adults; however,
decomposition of the findings revealed that, together,
the three major smoking-associated diseases contributedto 98.0% of the difference in LE between smokers and
non-smokers.
Several aspects have to be considered when discussing
the validity of these findings. First, the key new point in
our study design is that the smoking prevalence of surviv-
ing spouses of deceased subjects was used as a substitute
for the smoking prevalence of the base population; this
allowed us to calculate the cause-specific LEs by smoking
status. The basic assumption of this aspect of our study
design is that the distribution of all causes of death in
the base population is approximately random, as is the
distribution of living spouses, who can therefore be
regarded as a representative sample of the base population.
We have confirmed the validity of this technique in sev-
eral previous studies [14,15]. In addition, to support this
assumption, we compared the smoking prevalence in living
spouses with estimates of smoking prevalence from another
national study and found high consistency between them
[18]. Second, our figures for LEs regardless of smoking
status are consistent with LEs reported for the same
period in China [19], which also supports the validity of
Figure 1 Distribution of deaths from smoking-associated diseases among various age groups by sex and area of residence.
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LE. Third, because we obtained the information about
smoking habits from a retrospective mortality survey,
this information may have been influenced by recall bias.
Although findings from other studies have validated the
fact that smoking-associated LE decreases with increasing
numbers of smokers [8-10], we decided to minimize the in-
fluence of recall bias by simply dividing smoking informa-
tion into two definite categories (smoker and non-smoker),
since it is unlikely that many non-smokers would have
been misreported as having been smokers. In addition,
in a validity study in Shanghai in the early 1980s in
which the spouses were the informants and both hus-
band and wife reported their smoking habits, informa-
tion obtained from the wife on the husband’s smoking
habits was highly consistent with information provided
directly by the husband [20].
Smoking harms almost every organ in the body: previous
studies have demonstrated that many serious and fatal
diseases are caused by smoking [3]. However, in our
study, we mainly focused on neoplasms, respiratory
diseases and vascular diseases, which together account
for most deaths associated with smoking in China [21].
In addition, as a summary measure for health situation,
LE is not sensitive when disease categories are defined
in too much detail, especially when the diseases inquestion are associated with few deaths. Thus, the way
we categorized smoking-related diseases in our study en-
sured sufficient numbers of deaths in each disease category.
We compared our results with those of studies con-
ducted in other countries and found that the LE reductions
associated with smoking in our study were similar to
the findings of studies conducted in Japan [9,10]. How-
ever, in the United States, the difference in LE between
40-year-old smokers and non-smokers is reportedly ap-
proximately 6.9 years in men and 6.8 years in women
[5]. Research conducted in Austria found the LE difference
for 15-year-old men was 5.6 years [7]. A study conducted
in the Netherlands showed that the LE difference for
40-year-old subjects was 7.5 years [8]. The magnitude
of the reduction in LE associated with smoking in our
study was relatively small compared with that reported
by the above-mentioned studies. This disparity may be
attributable to differences between different countries
in the status of the smoking epidemic. In addition, the
mortality for the whole population in China was relatively
high [13]. Finally, the non-smoking group might have
included some passive smokers and ex-smokers, which
could have diluted the observed difference.
One interesting phenomenon in our findings that is
not consistent with widely held knowledge is that, even
though the death rate from vascular disease, which is a
Table 2 Life expectancy for smokers and non-smokers and potential gains in life expectancy (years) among men by
eliminating deaths from a specific smoking-associated disease by smoking status
Age group Overall life expectancy Gains in LE by eliminating
neoplasms
Gains in LE by eliminating
vascular diseases
Gains in LE by eliminating
respiratory diseases
Urban men Smokers Non-smokers Smokers Non-smokers Smokers Non-smokers Smokers Non-smokers
35-39 36.59 39.20 3.15 2.41 3.48 4.29 1.99 1.49
40-44 31.84 34.53 3.09 2.34 3.47 4.27 2.00 1.48
45-49 27.17 29.90 3.00 2.25 3.45 4.25 2.00 1.47
50-54 22.70 25.43 2.82 2.09 3.39 4.19 2.00 1.46
55-59 18.60 21.22 2.53 1.86 3.26 4.06 2.00 1.45
60-64 14.78 17.24 2.14 1.59 3.08 3.84 1.97 1.41
65-69 11.38 13.49 1.69 1.30 2.81 3.54 1.91 1.35
70-74 8.47 10.23 1.21 0.95 2.45 3.08 1.78 1.25
75-79 6.26 7.55 0.74 0.61 1.95 2.40 1.54 1.07
80+ 4.29 5.19 0.35 0.29 1.34 1.59 1.13 0.79
Rural men
35-39 35.23 37.50 3.10 2.78 2.43 2.99 2.86 2.37
40-44 30.64 33.10 3.01 2.67 2.41 2.98 2.87 2.35
45-49 26.16 28.73 2.86 2.51 2.40 2.96 2.88 2.33
50-54 21.88 24.54 2.62 2.28 2.36 2.93 2.88 2.30
55-59 17.88 20.53 2.28 2.01 2.30 2.86 2.85 2.24
60-64 14.23 16.92 1.86 1.63 2.20 2.70 2.78 2.12
65-69 11.13 13.66 1.35 1.21 2.04 2.46 2.62 1.94
70-74 8.42 10.68 0.89 0.83 1.80 2.14 2.36 1.69
75-79 6.28 8.11 0.50 0.47 1.43 1.62 1.94 1.34
80+ 4.18 5.39 0.25 0.22 1.01 1.13 1.39 0.95
Han et al. BMC Public Health 2013, 13:1147 Page 6 of 9
http://www.biomedcentral.com/1471-2458/13/1147major category of smoking-related disease, was greater
among smokers than non-smokers, we estimated that
vascular diseases were associated with loss of more life
years among non-smokers than among smokers. To
explore this unusual phenomenon, we employed the
LE decomposing techniques developed by Preston et al.
These techniques show that the difference in years of life
lost to a particular disease is equal to the amount of change
attributable to that disease in a cause-decomposition,
plus a simple additional term that reflects movements
in other causes of death. In our study, decomposition
showed that the contribution of vascular diseases to the
difference in LE between smokers and non-smokers was
positive (column 5 in Table 4), as was also true for neo-
plasms and respiratory diseases. However, other causes of
death, which of course included neoplasms and respiratory
diseases (column 4 in Table 4), made a greater contribution
to LE. That is, although the mortality rate decreased more
in smokers than in non-smokers after vascular diseases
had been eliminated, the size of the reduction in mortal-
ity for respiratory diseases or neoplasms outweighed
that for vascular diseases. In other words, the differencebetween smokers and non-smokers in life-shortening
effects resulting from elimination of vascular diseases
depends on the difference in mortality from respiratory
diseases and neoplasms, which was greater than that from
vascular diseases in our study.
The strengths of our study are as follows. First, rather
than calculating LE for all-cause deaths, the framework of
our new study design allowed assessment of the influence
of a specific major smoking-related disease on LE reduction
according to smoking status. This approach thus provides
policymakers and the general public with intuitive and
appropriate information concerning the adverse effect of
smoking on health. Second, although smoking, an import-
ant risk factor for death from cardiovascular diseases, had
indeed been proven to be associated with cardiovascular
disease in China, the risk is quite low compared with that
of neoplasms and respiratory disease according to a previ-
ous study based on this survey [13]. The present study fur-
ther evaluated the contribution of cardiovascular disease
and found that, after taking the change in mortality rates
related to other causes of death into account, cardiovascular
disease played a considerable role in the disparity in LEs.
Table 3 Life expectancy for smokers and non-smokers and potential gains in life expectancy (years) among women by
eliminating deaths from a specific smoking-associated disease by smoking status
Urban women Overall life expectancy Gains in LE by eliminating
neoplasms
Gains in LE by eliminating
vascular diseases
Gains in LE by eliminating
respiratory diseases
Smokers Non-smokers Smokers Non-smokers Smokers Non-smokers Smokers Non-smokers
35-39 38.51 40.87 2.54 1.92 3.76 4.12 2.37 1.57
40-44 33.71 36.09 2.51 1.86 3.75 4.10 2.35 1.57
45-49 29.05 31.35 2.39 1.78 3.69 4.06 2.34 1.56
50-54 24.59 26.81 2.23 1.65 3.55 3.96 2.33 1.54
55-59 20.39 22.5 1.99 1.45 3.38 3.79 2.30 1.52
60-64 16.36 18.37 1.70 1.22 3.17 3.57 2.23 1.49
65-69 12.78 14.52 1.33 0.96 2.89 3.26 2.11 1.42
70-74 9.64 11.05 0.92 0.67 2.53 2.83 1.92 1.30
75-79 7.10 8.00 0.55 0.41 2.01 2.23 1.59 1.10
80+ 4.78 5.29 0.25 0.20 1.38 1.47 1.17 0.82
Rural women
35-39 37.18 40.11 2.32 2.07 2.60 2.89 4.09 2.59
40-44 32.61 35.48 2.24 2.00 2.55 2.86 4.03 2.57
45-49 28.14 30.90 2.08 1.90 2.50 2.82 4.00 2.54
50-54 23.80 26.48 1.88 1.74 2.42 2.75 3.95 2.49
55-59 19.76 22.28 1.64 1.51 2.31 2.63 3.81 2.43
60-64 15.91 18.27 1.34 1.26 2.16 2.48 3.66 2.32
65-69 12.45 14.59 1.02 0.94 1.98 2.25 3.42 2.16
70-74 9.51 11.22 0.67 0.64 1.71 1.94 3.04 1.90
75-79 7.08 8.35 0.41 0.37 1.34 1.48 2.39 1.49
80+ 4.75 5.45 0.19 0.19 0.94 1.01 1.67 1.06
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portantly, it is based on a survey conducted two decades
ago, since which time the general smoking prevalence
has declined [22], which has probably influenced LE es-
timation by smoking status. However, because of the time
lag between smoking and the onset of smoking-related
disease, such decline in smoking prevalence would have
had a limited influence on life expectancy changes during
this period. Furthermore, we mainly estimated life years
lost due to smoking and the contributions of major smok-
ing related diseases (neoplasms, respiratory diseases and
cardiovascular diseases) to the life years lost by the risk of
deaths from those diseases; these have remained almost
unchanged for the last two decades. The relative risk of
death from these diseases for smokers has also remained
almost unchanged over time [21]. In addition, the LE dif-
ference between smokers and non-smokers in our study
was very close to that determined in a cohort study con-
ducted in Beijing in 2000 [23]. Therefore, in the current
study the changes in smoking status would have had lim-
ited influence on the estimated LE lost due to smoking
and the contributions of smoking-related diseases to the
life years lost. Second, although we stratified our analysesby age, sex and region, we could not make direct adjust-
ments for socioeconomic status and unhealthy behaviors
such as alcohol intake because information about these
was not available. This may have caused under-estimation
of the LE gap between smokers and non-smokers [24].
Third, we did not include the smoking status of ex-smoker
in our study, which may have led to some under-estimation
of the difference in LE. However, the influence of not
considering ex-smokers separately would have been lim-
ited because smoking cessation is a relatively infrequent
event in China. This is likely a consequence of the wide
cultural acceptance that smoking continues to enjoy in
China: most smokers quit smoking only when an illness
is established [25]. Finally, we assessed only 90% of all
deaths over the age of 35 years and smoking information
was missing in 6% of our subjects. Although we made
adjustments by reducing the base population estimate
by 10% and excluding those without smoking information
when calculating both death rates and smoking-specific
death rates, the missing information may still have had
an influence on our findings. However, the findings are
unlikely to have been seriously distorted because the
death patterns of deceased subjects who had no death
Figure 2 Sex- and area-specific decomposition results of life expectancy reductions associated with smoking.
Table 4 Sex- and area-specific decomposition results of the difference in gained life expectancy (years) estimated by
elimination of major smoking-associated diseases
Cause of death Gains in LE by
eliminating a cause of
death for non-smokers (1)
Gains in LE by
eliminating a cause of
death for smokers (2)
Difference
(3)=(2)-(1)






Neoplasm 2.41 3.15 0.74 −0.45 1.19
Vascular disease 4.29 3.48 −0.81 −1.19 0.38
Respiratory disease 1.49 1.99 0.51 −0.40 0.91
Rural men
Neoplasm 2.78 3.10 0.33 −0.51 0.84
Vascular disease 2.99 2.43 −0.56 −0.86 0.31
Respiratory disease 2.37 2.86 0.49 −0.55 1.04
Urban women
Neoplasm 1.92 2.54 0.63 −0.28 0.90
Vascular disease 4.12 3.76 −0.36 −0.82 0.47
Respiratory disease 1.57 2.37 0.80 −0.26 1.06
Rural women
Neoplasm 2.07 2.32 0.25 −0.39 0.64
Vascular disease 2.89 2.60 −0.29 −0.71 0.42
Respiratory disease 2.59 4.09 1.50 −0.33 1.83
*Changed significance of a smoking-associated cause of death that is estimated by changes in other causes of death in smokers and non-smokers.
ŦLife expectancy disparity between smokers and non-smokers that was attributable to a particular smoking-associated cause of death.
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mation were probably similar to that of the subjects in-
cluded in the study.
In summary, our findings suggest that respiratory
disease has the greatest influence on the LE reduction
associated with smoking. Thus, smoking prevention
could significantly reduce deaths from respiratory dis-
ease and improve LE. This finding may have important





The authors declare they have no competing interests.
Authors’ contributions
All authors listed in our manuscript have contributed substantially to this
work. BL: corresponding author, responsible for obtaining permission from all
co-authors for submission of the manuscript and responsible for any changes
in authorship of the manuscript; WH, JJ: joint first authors, responsible for
analyzing the data, writing the manuscript, and the accuracy of the research;
JL, YW, YC: responsible for study design and data collection; XZ, XZ: responsible
for supervising data collection as well as quality control of the data coding; LH,
HP: participated in manuscript modification before submission. All authors read
and approved the final manuscript.
Acknowledgments
This work was supported by Cancer Research UK, the UK Medical Research
Council, the US National Institutes of Health, the Chinese Ministry of Health,
and the Chinese Academy of Medical Sciences. We thank Professor Richard
Peto, who gave us great support for the project. The cooperation of the
local government, the thousands of doctors, nurses, and other field workers
who conducted the surveys, and the million interviewees are gratefully
acknowledged.
Author details
1Department of Epidemiology and Biostatistics, Institute of Basic Medical
Science, Chinese Academy of Medical Sciences & School of Basic Medicine,
Peking Union Medical College, Beijing, China. 2The Cancer Institute/Hospital,
Chinese Academy of Medical Sciences, 17 Pan Jia Yuan Nan Li, Beijing
100021, China.
Received: 10 February 2013 Accepted: 3 December 2013
Published: 9 December 2013
References
1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and
regional burden of disease and risk factors, 2001: systematic analysis of
population health data. Lancet 2006, 367:1747–1757.
2. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Comparative
Risk Assessment Collaborating Group: Selected major risk factors and
global and regional burden of disease. Lancet 2002, 360:1347–1360.
3. Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking:
50 years’ observations on male British doctors. BMJ 2004, 328:1519–1528.
4. Phillips AN, Wannamethee SG, Walker M, Thomson A, Smith GD: Life
expectancy in men who have never smoked and those who have
smoked continuously: 15 year follow up of large cohort of middle aged
British men. BMJ 1996, 313:907–908.
5. Rogers RG, Powell-Griner E: Life expectancies of cigarette smokers and
nonsmokers in the United States. SocSci Med 1991, 32:1151–1159.
6. Prescott E, Osler M, Hein HO, Borch-Johnsen K, Schnohr P, Vestbo J: Life
expectancy in Danish women and men related to smoking habits: smoking
may affect women more. J Epidemiol Community Health 1998, 52:131–132.
7. Taylor R: Estimating risk of tobacco-induced mortality from readily
available information. Tob Control 1993, 2:18–23.8. Streppel MT, Boshuizen HC, Ocké MC, Kok FJ, Kromhout D: Mortality and
life expectancy in relation to long-term cigarette, cigar and pipe
smoking: the Zutphen Study. Tob Control 2007, 16:107–113.
9. Ozasa K, Katanoda K, Tamakoshi A, Sato H, Tajima K, Suzuki T, Tsugane S,
Sobue T: Reduced life expectancy due to smoking in large-scale cohort
studies in Japan. J Epidemiol 2008, 18:111–118.
10. Murakami Y, Ueshima H, Okamura T, Kadowaki T, Hozawa A, Kita Y,
Hayakawa T, Okayama A, NIPPON DATA80 Research Group: Life expectancy
among Japanese of different smoking status in Japan: NIPPON DATA80.
J Epidemiol 2007, 17:31–37.
11. Yang G, Fan L, Tan J, Qi G, Zhang Y, Samet JM, Taylor CE, Becker K, Xu J:
Smoking in China: finding of the 1996 national prevalence survey.
JAMA 1999, 282:1247–1253.
12. Gu D, Wu X, Reynolds K, Duan X, Xin X, Reynolds RF, Whelton PK, He J,
InterASIA Collaborative Group: Cigarette smoking and exposure to
environmental tobacco smoke in China: the international collaborative study
of cardiovascular disease in Asia. Am J Public Health 2004, 94:1972–1976.
13. Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY, Campbell TC, Chen JS:
Emerging tobacco hazards in China: 1. Retrospective proportional
mortality study of one million deaths. BMJ 1998, 317:1411–1422.
14. Jiang J, Liu B, Sitas F, Li J, Zeng X, Han W, Zou X, Wu Y, Zhao P:
Smoking-attributable deaths and potential years of life lost from a large,
representative study in China. Tob Control 2010, 19:7–12.
15. Jiang J, Liu B, Nasca PC, Han W, Zou X, Zeng X, Tian X, Wu Y, Zhao P, Li J:
Comparative study of control selection in a national population-based
case–control study: estimating risk of smoking on cancer deaths in Chinese
men. Int J Med Sci 2009, 6:329–337.
16. Preston SH, Heuveline P, Guillot M: Demography, measuring and modeling
population process. Oxford, UK: Blackwell Publishers Ltd; 2001.
17. Beltrán-Sánchez H, Preston SH, Canudas-Romo V: An integrated approach
to cause-of-death analysis: cause-deleted life tables and decompositions
of life expectancy. Demogr Res 2008, 19:1323–1359.
18. Weng XZ: Report on the 1984 Chinese national smoking prevalence survey.
Beijing: People’s Medical Publishing House; 1988.
19. Lu L, Hao H, Lingao: Abridge life table in China in 1990 (in Chinese).
Popul Res 1994, 18:52–59.
20. Deng J: The prevalence of smoking habit among 110 000 adult residents
in urban Shanghai [in Chinese]. Zhonghua Yu Fang Yi Xue Za Zhi 1985,
5:271–274.
21. Gu D, Kelly TN, Wu X, Chen J, Samet JM, Huang JF, Zhu M, Chen JC, Chen
CS, Duan X, Klag MJ, He J: Mortality attributable to smoking in China.
N Engl J Med 2009, 360:150–159.
22. Qian J, Cai M, Gao J, Tang S, Xu L, Critchley JA: Trends in smoking and
quitting in china from 1993 to 2003. National health service survey data.
Bull World Health Organ 2010, 88:769–776.
23. Tian X, Tang Z, Jiang J, Fang X, Wu X, Han W, Guan S, Liu H, Diao L, Sun F:
Effects of smoking and smoking cessation on life expectancy in an
elderly population in Beijing, China, 1992–2000: an 8-year follow-up
study. J Epidemiol 2011, 21:376–384.
24. Adler NE, Boyce T, Chesney MA, Cohen S, Folkman S, Kahn RL, Syme SL:
Socioeconomic status and health: the challenge of the gradient.
Am Psychol 1994, 49:15–24.
25. Yang G, Ma J, Chen A, Zhang Y, Samet JM, Taylor CE, Becker K: Smoking
cessation in China: findings from the 1996 national prevalence survey.
Tob Control 2001, 10:170–174.
doi:10.1186/1471-2458-13-1147
Cite this article as: Han et al.: Contributions of major smoking-related
diseases to reduction in life expectancy associated with smoking in
Chinese adults: a cross-sectional study. BMC Public Health 2013 13:1147.
